Reply  by Rockman, Caron
operating on symptomatic patients 4 weeks of presentation is to
be strongly commended!
A. Ross Naylor, MD, FRCS
Leicester Royal Infirmary
Leicester, United Kingdom
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Reply
We greatly appreciate the interest of Professor Naylor and his
insightful comments on our article “Early carotid endarterectomy
in symptomatic patients is associated with poorer perioperative
outcomes,” (J Vasc Surg 2006;44:480-7) and on our published
results. Certainly, it was an acknowledged limitation of our manu-
script that we, unfortunately, did not have information on recur-
rent cerebrovascular events that may have occurred in patients
subjected to an arbitrary “waiting period” before carotid endarter-
ectomy (CEA) after an initial stroke.
In addition, we certainly agree wholeheartedly with Professor
Naylor regarding his point that one’s objectives should be to
provide the best long-term outcome for the individual patient, and
not simply to try to attain the lowest periprocedural complication
rate in an attempt to win a “beauty contest.” His comment that
even a 10% procedural risk with surgery performed2 weeks of an
index stroke might prove worthwhile in the long term is certainly
thought provoking, and may very well be perfectly true.
However, another focus of our work was to focus on the
mechanisms of perioperative stroke in patients operated on soon
after an index stroke, and analysis in an attempt to define which
stroke patients (if any) might be better served with delayed inter-
vention as opposed to an earlier approach. We were hopeful that
this information might help clinicians decide the optimal time to
intervention on each individual patient to provide that patient the
best long-term outcome. The relatively high incidence of periop-
erative morbidity due to cerebral hyperperfusion or hemorrhage,
or both, in some stroke patients who underwent early intervention
was concerning to us; unfortunately, I do not believe at this point
that it is possible to predict this outcome with any degree of
accuracy in an individual case.
Regarding the EVA-3S results and the high rate of early
intervention in the angioplasty arm of this trial, I would agree that
this may be partially responsible for the “poor” outcome in these
cases. I will also note results from an abstract to be presented at this
year’s Annual SVS Meeting by McPhee and colleagues from the
University of Massachusetts and Temple University Medical
School.1 In analysis of 217,468 patient discharges from the Na-
tionwide Inpatient Sample after revascularization for carotid artery
stenosis, this study abstract reports a 9.5% periprocedural mortality
rate after carotid artery angioplasty and stenting (CAS) for patients
with a diagnosis of stroke, as opposed to a 2.0% perioperative
mortality rate after CEA. In light of Professor Naylor’s comments,
one wonders whether CAS is generally being performed earlier
after stroke than CEA.
Caron Rockman, MD, FACS
Associate Professor of Surgery
New York University Medical School
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Regarding: “A modified calculation of ankle-brachial
pressure index is far more sensitive in the detection of
peripheral arterial disease”
We read with great interest the report by Dr Schröder et al1 on
a new mode of ankle-brachial index (ABI) calculation. Accord-
ingly, we believe that ABI measurement should be standardized,
facilitating comparability. Nonetheless, their results suggest a new
mode of ABI determination needing further investigations and
deferring temporarily the proposition of a unique mode of ABI
calculation. Indeed, several studies2,3 have compared different
modes of ABI calculation, but the use of the lowest of both ankle
arteries as the ABI numerator had never been assessed. In their
comparison vs color duplex ultrasound imaging,1 the authors
concluded that the use of the lowest ankle pressure (LAP) instead
of the highest ankle pressure (HAP) could increase the diagnostic
abilities of the ABI to detect peripheral arterial disease (PAD).
Because the generalization of ABI measurement in primary
care is mandatory,4 we have several concerns about a wide use of
this mode of calculation in clinical practice. First, their report1
presents ABI results as below or 0.90, but we do not find any
information on those with a missing arterial signal, which would
lead to an ABI  0. This situation is usually due to an arterial
occlusion but can also be present in case of an arterial hypoplasia,
which may occur for the dorsalis pedis artery in 4% to 12% of the
general population.5 Because the study participants were outpa-
tient vascular patients, an absent dorsalis pedis Doppler signal is
probably due to a diseased artery, but this cannot be extrapolated
to the general population with its lower risk of PAD.
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Fig. Strokes prevented per 1000 CEAs at 5 years stratified for (1)
delay from last event to surgery and (2) 30-day death/stroke rate.
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